SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Equities research analysts at Desjardins issued their Q1 2025 earnings per share (EPS) estimates for SNC-Lavalin Group in a research report issued to clients and investors on Friday, March 14th. Desjardins analyst B. Poirier forecasts that the company will post earnings per share of $0.51 for the quarter. Desjardins also issued estimates for SNC-Lavalin Group’s Q2 2025 earnings at $0.59 EPS, Q3 2025 earnings at $0.82 EPS and Q4 2025 earnings at $0.99 EPS.
Separately, Stifel Canada upgraded SNC-Lavalin Group to a “strong-buy” rating in a research note on Tuesday, February 4th.
SNC-Lavalin Group Stock Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Featured Stories
- Five stocks we like better than SNC-Lavalin Group
- 3 Small Caps With Big Return Potential
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Learn Technical Analysis Skills to Master the Stock Market
- 3 Must-Own Stocks to Build Wealth This Decade
- What Investors Need to Know About Upcoming IPOs
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
